Medicinal Plants as A Potential Source for the Creation of Brand new Drugs

Xiaoli Marie*

Department of Clinical Research, University of Southern Denmark, Odense, Denmark

*Corresponding Author:
Xiaoli Marie
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
E-mail: xiaoli@gmail.com

Received date:  December 07, 2022, Manuscript No. IPGJRR-23-15821; Editor assigned date:  December 09, 2022, PreQC No IPGJRR-23-15821 (PQ); Reviewed date:  December 19, 2022, QC No. IPGJRR-23-15821; Revised date:  December 26, 2022, Manuscript No.IPGJRR-23-15821 (R); Published date: January 06, 2023, DOI: 10.36648/2393-8854.10.1.32
Citation:  Marie X (2023) Medicinal Plants as a Potential Source for the Creation of Brand New Drugs. Glob J Res Rev.10.1.32

Visit for more related articles at Global Journal of Research and Review

Description

Millions of people around the world have contracted sexually transmitted diseases, which have a negative impact on their emotional, social, and financial quality of life. Despite the fact that, as the name implies, sexual contact is the primary method of transmission for Sexually Transmitted Diseases (STDs), there have been instances of non-sexual transmission. The only way to manage and stop this condition is with the right diagnosis. There are a variety of detection methods for STDs, including PCR and serological tests; however, these procedures have a number of drawbacks, including the fact that they are less sensitive, more expensive, and require an expert. Due to its numerous advantages, including early detection, low cost, robustness, high sensitivity, and specificity, a newly developed method known as a biosensor is used to overcome these limitations in the diagnosis of this disease. This device is more reliable than the conventional one. The World Health Organization's Global health sector plan on STIs calls for biosensors for Sexually Transmitted Infections (STIs) as its foundation from 2016 to 2021. Through multiplexing, some biosensors can simultaneously detect two or more causal agents, making them much more useful. Biosensors for STDs have made significant progress in recent years. The purpose of this review is to discuss STDs, their prevalence and severity, the drawbacks of the current methods, and how these biosensors are a beacon of hope in providing highly sought-after, accurate, and portable devices. Worldwide, approximately one million new cases of Sexually Transmitted Diseases (STDs) are reported each day. Because STD pathogens are becoming resistant to antibiotics, which are cause for concern, it is necessary to develop new medications for the treatment of STDs. As a result, there has been an increase in curiosity regarding the evaluation of medicinal plants as a potential source for the creation of brand-new drugs. The purpose of this study was to determine the antioxidant effects, cytotoxic effects, and potential cytotoxicity of nine ethanolic plant extracts chosen for their antimicrobial activity against four STD pathogens, two STD-associated cancer cell lines, and one non-tumorigenic cell line.

Sexually Transmitted Disease

Three STD pathogens were tested for the extracts' antimicrobial activity: Microdilution of Neisseria gonorrhoeae, Candida albicans, and Gardnerella vaginalis Furthermore, a selection of extracts were tested on Malassezia furfur using the disk diffusion technique. Since the pathogens used in the study cause persistent inflammation, further investigation into the extracts' DPPH and NO radical scavenging abilities was conducted. Human squamous cell carcinoma (A431), human keratinocytes (HaCat), and human cervical adenocarcinoma cell lines were also used to test the extracts' cytotoxic effects. With Minimal Inhibitory Concentrations (MICs) of 0.78 and 0.39 mg/mL, respectively, the root extract of Rhoicissus tridentata demonstrated the greatest antimicrobial activity against C. albicans and N. gonorrhoeae. Due to its significant antimicrobial and antioxidant activity, the study's findings revealed that R. tridentata is a potential candidate for further investigation into its use in the treatment of STDs. R. tridentata's cytotoxic effects on selected cell lines, NO scavenging properties, and antimicrobial activity against M. furfur are all first reported in this study. Beliefs and actions related to the spread of Sexually Transmitted Diseases (STDs), a persistent public health issue, can be influenced by traumatizing experiences. To estimate how combat exposure alters a surviving male veteran's likelihood of contracting a sexually transmitted disease, I make use of a natural experiment that was brought about by variations in the locations at which members of the United States military deploy. To reduce estimates' sensitivity to small samples, a rarely observed outcome, and highly correlated covariates, I employ information theoretic methods to analyze longitudinal data on 485 deployed veterans from 1994 to 2008. I estimate that combat exposure increases the likelihood of contracting a STD by 5.4 percentage points for veterans assigned to a combat zone. There is evidence from additional estimations that substance use or multiple sexual partners may be risky behaviors that can lead to STDs from combat exposure. Discussions regarding STD screening and the requirements for care for traumatized individuals can benefit from my findings. Many outcomes, such as HIV risk, other sexually transmitted diseases, and unintended pregnancy, are influenced by adolescents' health behaviors and experiences. Schools are an essential venue for public health interventions and approaches that address risk behaviors or experiences in adolescence. These interventions and approaches have the potential to have wide-reaching effects on sexual health and other related outcomes across the lifespan. For the purpose of preventing HIV/sexually transmitted diseases, unintended pregnancy, and related health risk behaviors and experiences among middle and high school students, this paper describes a school-based program.

Viral Infections

This includes a description of the model's activities, organized into three key strategies (sexual health education, sexual health services, and safe and supportive environments) and three cross-domains (strengthening staff capacity, increasing student access to programs and services, and engaging parent and community partners), as well as a summary of the theoretical and empirical foundations that support the model. Adolescent health professionals and organizations working in schools, clinics, and communities to address and promote adolescents' sexual health and well-being are also discussed in the paper. State and local budgetary issues are jeopardizing specialized Sexually Transmitted Disease (STD) care, putting at risk the highest ever reported levels of bacterial sexually transmitted infections in the United States. In order to determine the needs of patients and the capabilities of clinics, this study gathered data from 4138 people seeking treatment at 26 STD clinics in large metropolitan areas across the United States with high rates of reported STDs. Patients at these STD clinics were asked to fill out surveys to find out about their demographics and the reasons they came to the clinic. Clinic administrators were also asked to fill out surveys to find out how well they could run the clinic and what services it offered. We used univariate analyses to report all survey data for this initial investigation. Patients who go to STD clinics all over the country said they do so because it's easy to get an appointment; including same-day and walk-in appointments, a warm atmosphere, and the clinic's staff's expertise. Additionally, patients receive specialized care from STD clinics; including HIV counseling and testing, as well as on-site injections for gonorrhea and syphilis treatment, in a setting that helps to lessen the stigma associated with seeking this kind of care. Clinics for sexually transmitted diseases continue to make a significant contribution to the fight against the growing problem of sexually transmitted infections. Sexually Transmitted Infections (STI) represents a significant disease burden, with over 374 million new cases of curable STI occurring annually worldwide. This article highlights key factors affecting public health and the global burden of STI and examines the epidemiology of STI, a diverse group of pathogens primarily transmitted through sexual contact. The following are some of the most common persistent viral infections and treatable bacterial infections covered in this article: chlamydia, syphilis, herpes simplex, and human papillomavirus, hepatitis B virus, and human immunodeficiency virus. Additionally, the article provides some general strategies for care and management. The article suggests that, ultimately, there remains a pressing need for greater investment in effective STD treatment, diagnosis, prevention, and surveillance. It concludes with a discussion of opportunities for sexual health gain and the control of STI.

Select your language of interest to view the total content in your interested language

Viewing options

Flyer image
journal indexing image

Share This Article